A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Patients With Influenza A Infection
Phase of Trial: Phase II
Latest Information Update: 28 Jun 2017
At a glance
- Drugs Pimodivir (Primary) ; Oseltamivir
- Indications Influenza A virus infections
- Focus Pharmacokinetics
- Acronyms OPAL
- Sponsors Janssen Research & Development
- 22 Jun 2017 Status changed from active, no longer recruiting to completed.
- 03 Jun 2017 This trial has been completed in Spain (end date: 15 Mar 2017).
- 19 May 2017 Status changed from recruiting to active, no longer recruiting.